137 related articles for article (PubMed ID: 8006409)
1. Ascites apheresis, concentration and reinfusion for the treatment of massive or refractory ascites in cirrhosis.
Bernardi M; Rimondi A; Gasbarrini A; Trevisani F; Caraceni P; Legnani C; Palareti G; Gasbarrini G
J Hepatol; 1994 Feb; 20(2):289-95. PubMed ID: 8006409
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic and renal effects of ascites apheresis, concentration and reinfusion in advanced cirrhosis.
Bernardi M; Gasbarrini A; Trevisani F; Caraceni P; De Collibus C; Colantoni A; Andreone P; Cursaro C; Ligabue A; Gasbarrini G
J Hepatol; 1995 Jan; 22(1):10-6. PubMed ID: 7751575
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
[TBL] [Abstract][Full Text] [Related]
4. Comparison of spontaneous ascites filtration and reinfusion with total paracentesis with intravenous albumin infusion in cirrhotic patients with tense ascites.
Bruno S; Borzio M; Romagnoni M; Battezzati PM; Rossi S; Chiesa A; Podda M
BMJ; 1992 Jun; 304(6843):1655-8. PubMed ID: 1633517
[TBL] [Abstract][Full Text] [Related]
5. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
[TBL] [Abstract][Full Text] [Related]
6. Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trial of spironolactone versus placebo.
Fernández-Esparrach G; Guevara M; Sort P; Pardo A; Jiménez W; Ginès P; Planas R; Lebrec D; Geuvel A; Elewaut A; Adler M; Arroyo V
J Hepatol; 1997 Mar; 26(3):614-20. PubMed ID: 9075669
[TBL] [Abstract][Full Text] [Related]
7. Reinfusion of concentrated ascitic fluid versus total paracentesis. A randomized prospective trial.
Graziotto A; Rossaro L; Inturri P; Salvagnini M
Dig Dis Sci; 1997 Aug; 42(8):1708-14. PubMed ID: 9286238
[TBL] [Abstract][Full Text] [Related]
8. Clinical and neurohumoral response to posture, physical exercise, and ascites treatment in Child-Pugh C liver cirrhosis: randomized prospective trial.
Degoricija V; Zjacic-Rotkvic V; Marout J; Sefer S; Troskot B
Croat Med J; 2003 Apr; 44(2):178-86. PubMed ID: 12698509
[TBL] [Abstract][Full Text] [Related]
9. Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study.
Planas R; Ginès P; Arroyo V; Llach J; Panés J; Vargas V; Salmerón JM; Ginès A; Toledo C; Rimola A
Gastroenterology; 1990 Dec; 99(6):1736-44. PubMed ID: 1699835
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic changes in patients developing effective hypovolemia after total paracentesis.
Vila MC; Solà R; Molina L; Andreu M; Coll S; Gana J; Marquez J; Palá J; Bory F; Pons S; Szescielinski L; Jimenez W
J Hepatol; 1998 Apr; 28(4):639-45. PubMed ID: 9566833
[TBL] [Abstract][Full Text] [Related]
11. Atrial natriuretic factor in cirrhotic patients with tense ascites. Effect of large-volume paracentesis.
Salerno F; Badalamenti S; Moser P; Lorenzano E; Incerti P; Dioguardi N
Gastroenterology; 1990 Apr; 98(4):1063-70. PubMed ID: 2138104
[TBL] [Abstract][Full Text] [Related]
12. Prospective study comparing human albumin vs. reinfusion of ultrafiltrate-ascitic fluid after total paracentesis in cirrhotic patients with tense ascites.
Zaak D; Paquet KJ; Kuhn R
Z Gastroenterol; 2001 Jan; 39(1):5-10. PubMed ID: 11215366
[TBL] [Abstract][Full Text] [Related]
13. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
Tan HK; James PD; Wong F
Dig Dis Sci; 2016 Oct; 61(10):3084-3092. PubMed ID: 27048451
[TBL] [Abstract][Full Text] [Related]
14. Aldosterone related blood volume expansion in cirrhosis before and during the early phase of ascites formation.
Bernardi M; Trevisani F; Santini C; De Palma R; Gasbarrini G
Gut; 1983 Aug; 24(8):761-6. PubMed ID: 6347831
[TBL] [Abstract][Full Text] [Related]
15. Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis: a randomized controlled study.
Solà R; Vila MC; Andreu M; Oliver MI; Coll S; Gana J; Ledesma S; Ginès P; Jiménez W; Arroyo V
J Hepatol; 1994 Feb; 20(2):282-8. PubMed ID: 7516361
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
17. Renin, aldosterone and renal haemodynamics in cirrhosis with ascites.
Arroyo V; Bosch J; Mauri M; Viver J; Mas A; Rivera F; Rodes J
Eur J Clin Invest; 1979 Feb; 9(1):69-73. PubMed ID: 110603
[TBL] [Abstract][Full Text] [Related]
18. [Changes in antidiuretic hormone (ADH) in liver cirrhosis with resistant ascites].
Marenco G; Giudici Cipriani A; Folco U; Colombo P; Menardo G; Cattana A; Barbetti V; Rembado R
Minerva Med; 1989 Sep; 80(9):959-64. PubMed ID: 2682381
[TBL] [Abstract][Full Text] [Related]
19. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
Appenrodt B; Wolf A; Grünhage F; Trebicka J; Schepke M; Rabe C; Lammert F; Sauerbruch T; Heller J
Liver Int; 2008 Aug; 28(7):1019-25. PubMed ID: 18410283
[TBL] [Abstract][Full Text] [Related]
20. Effective plasma volume in cirrhosis with ascites. Evidence that a decreased value does not account for renal sodium retention, a sponteneous reduction in glomerular filtration rate (GFR), and a fall in GFR during drug-induced diuresis.
Lieberman FL; Ito S; Reynolds TB
J Clin Invest; 1969 Jun; 48(6):975-81. PubMed ID: 5771197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
